DRW Securities as of Sept. 30, 2018
Portfolio Holdings for DRW Securities
DRW Securities holds 41 positions in its portfolio as reported in the September 2018 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Spdr S&p 500 Etf (SPY) | 88.0 | $1.6B | 5.5M | 290.72 | |
| SPDR Gold Trust (GLD) | 9.1 | $166M | 1.5M | 112.76 | |
| SPDR Dow Jones Industrial Average ETF (DIA) | 0.6 | $11M | 42k | 264.39 | |
| iShares Silver Trust (SLV) | 0.3 | $6.0M | 436k | 13.73 | |
| iShares Barclays 20+ Yr Treas.Bond (TLT) | 0.3 | $4.7M | 40k | 117.28 | |
| iShares Russell 2000 Index (IWM) | 0.2 | $4.1M | 25k | 168.54 | |
| Garrison Capital | 0.2 | $3.6M | 434k | 8.28 | |
| ProShares UltraPro S&P 500 (UPRO) | 0.1 | $2.0M | 35k | 57.27 | |
| Invesco Qqq Trust Series 1 (QQQ) | 0.1 | $2.0M | 11k | 185.78 | |
| Vaneck Vectors Russia Index Et | 0.1 | $1.8M | 83k | 21.56 | |
| Proshares Tr short s&p 500 ne | 0.1 | $1.7M | 63k | 27.32 | |
| Interpublic Group of Companies (IPG) | 0.1 | $1.5M | 64k | 22.89 | |
| Anheuser-Busch InBev NV (BUD) | 0.1 | $1.5M | 17k | 87.53 | |
| Proshares Tr ultrapro qqq (TQQQ) | 0.1 | $1.5M | 21k | 71.16 | |
| ProShares Ultra QQQ (QLD) | 0.1 | $1.3M | 13k | 100.67 | |
| Proshares Tr ultrapro short s | 0.1 | $1.1M | 33k | 32.22 | |
| Prudential Financial (PRU) | 0.1 | $851k | 8.4k | 101.31 | |
| Barrick Gold Corp | 0.0 | $670k | 61k | 11.07 | |
| Aldeyra Therapeutics (ALDX) | 0.0 | $561k | 41k | 13.79 | |
| Aptose Biosciences | 0.0 | $573k | 220k | 2.60 | |
| Bojangles | 0.0 | $535k | 34k | 15.69 | |
| Proshares Ultrashort S&p 500 | 0.0 | $503k | 15k | 33.12 | |
| Jeld-wen Hldg Inc call | 0.0 | $466k | 19k | 24.66 | |
| Sesen Bio | 0.0 | $538k | 250k | 2.15 | |
| Tronox | 0.0 | $442k | 37k | 11.95 | |
| Genocea Biosciences | 0.0 | $366k | 469k | 0.78 | |
| Immune Design | 0.0 | $276k | 80k | 3.45 | |
| Pieris Pharmaceuticals | 0.0 | $448k | 80k | 5.60 | |
| Direxion Shs Etf Tr daily sm cap bea | 0.0 | $373k | 44k | 8.41 | |
| Leap Therapeutics | 0.0 | $378k | 49k | 7.79 | |
| Microsoft Corporation (MSFT) | 0.0 | $229k | 2.0k | 114.50 | |
| New Gold Inc Cda (NGD) | 0.0 | $262k | 345k | 0.76 | |
| Affimed Therapeutics B V | 0.0 | $119k | 27k | 4.34 | |
| Contrafect | 0.0 | $150k | 73k | 2.07 | |
| Oncosec Med | 0.0 | $210k | 150k | 1.40 | |
| Eiger Biopharmaceuticals | 0.0 | $177k | 15k | 12.00 | |
| Molecular Templates | 0.0 | $239k | 44k | 5.40 | |
| Alpine Immune Sciences | 0.0 | $182k | 29k | 6.34 | |
| Cue Biopharma (CUE) | 0.0 | $181k | 20k | 9.05 | |
| MDC PARTNERS INC CL A SUB Vtg | 0.0 | $88k | 21k | 4.13 | |
| Proteon Therapeutics | 0.0 | $48k | 25k | 1.93 |
